The Current Ratio as of December 2025 (TTM) for Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) is 2.84

According to Zhejiang Ausun Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.84. This represents a change of 5.39% compared to the average of 2.69 of the last 4 quarters.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Historical Current Ratio (quarterly & annually)

How has 603229.SS Current Ratio performed in the past?

The mean historical Current Ratio of Zhejiang Ausun Pharmaceutical Co., Ltd. over the last ten years is 2.28. The current 2.84 Current Ratio has changed 12.35% with respect to the historical average. Over the past ten years (40 quarters), 603229.SS's Current Ratio was at its highest in in the March 2021 quarter at 4.62. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Zhejiang Ausun Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Average Current Ratio

How has 603229.SS Current Ratio performed in the past?

The current Current Ratio of Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Current Ratio vs. Peers

How is 603229.SS’s Current Ratio compared to its peers?

Zhejiang Ausun Pharmaceutical Co., Ltd.’s Current Ratio is greater than Anhui Huaheng Biotechnology Co., Ltd. (1.44), less than Hunan Jiudian Pharmaceutical Co., Ltd. (4.81), less than Guilin Sanjin Pharmaceutical Co., Ltd. (3.13), greater than Kexing Biopharm Co., Ltd. (1.50), less than Aurisco Pharmaceutical Co.,Ltd. (4.30), less than PharmaBlock Sciences (Nanjing), Inc. (4.59), less than Daan Gene Co., Ltd. (3.06), less than Wuhan Keqian Biology Co.,Ltd (5.30), greater than Chengzhi Shareholding Co., Ltd. (1.46), less than Chengdu Kanghua Biological Products Co., Ltd. (5.85),

Build a custom stock screener for Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Ausun Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Ausun Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.